The role of CCR4, CCR8, CCR10, and CCR6 or their ligands has been proposed in atopic dermatitis (AD), psoriasis, cutaneous lupus erythematosus, systemic sclerosis, or malignant skin tumors, but not in CU [8,9,10,11]. This evidence concerns the gene CCR4 and systemic sclerosis.